Bull and BearThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday.

Abbott Laboratories (NYSE: ABT) started as Outperform at William Blair.

BlackRock Inc. (NYSE: BLK) started as Overweight at J.P. Morgan.

Boston Beer Co. (NYSE: SAM) started as Neutral at Citigroup.

Craft Brew Alliance Inc. (NASDAQ: BREW) started as Neutral at Citigroup.

DaVita HealthCare Partners Inc. (NYSE: DVA) started as Overweight at JPMorgan.

EverestRe (NYSE: RE) raised to Overweight at J.P. Morgan.

Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) raised to Buy at Deutsche Bank.

HomeAway Inc. (NASDAQ: AWAY) raised to Overweight at Barclays.

LinnCo (NASDAQ: LNCO) started as Outperform at Wells Fargo.

Molson Coors Brewing Co. (NYSE: TAP) started as Neutral at Citigroup.

Partner Re (NYSE: PNR) cut to Underweight at J.P. Morgan.

Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) raised to Buy at BofA/Merrill Lynch.

Here are some other outside (and internal) outlook pieces for the end of 2012 and 2013:

  • Nine Big Biotech Winners for 2013
  • Imagine this: Coal could be a top performer in 2013 after two really bad years.
  • Fortune's Top 10 Stocks to Buy for 2013
  • BofA's 10 Defensive and Yield Stock Picks for 2013
  • S&P 500 Upside Targets for 2013, from everyone

JON C. OGG


Filed under: 24/7 Wall St. Wire, Analyst Calls Tagged: ABT, AWAY, BLK, BREW, DVA, FCX, LNCO, PNR, RE, SAM, TAP, TKC

Increase your money and finance knowledge from home

Goal Setting

Want to succeed? Then you need goals!

View Course »

Portfolio Basics

What are stocks? Learn how to start investing.

View Course »

Add a Comment

*0 / 3000 Character Maximum